Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination Article Swipe
Alexander Hönning
,
Sara Tomczyk
,
Júlia Hermes
,
Marica Grossegesse
,
Natalie Hofmann
,
Janine Michel
,
Markus Neumann
,
Andreas Nitsche
,
Berthold Hoppe
,
Tim Eckmanns
,
Hajo Schmidt-Traub
,
Kristina Zappel
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1186/s12879-024-09338-5
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1186/s12879-024-09338-5
Related Topics
Concepts
Serology
Medicine
Vaccination
Pandemic
Coronavirus disease 2019 (COVID-19)
Immunology
Cohort study
Virology
Antibody
Internal medicine
Disease
Infectious disease (medical specialty)
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1186/s12879-024-09338-5
- OA Status
- gold
- Cited By
- 6
- References
- 37
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4395078149
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4395078149Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s12879-024-09338-5Digital Object Identifier
- Title
-
Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccinationWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-04-24Full publication date if available
- Authors
-
Alexander Hönning, Sara Tomczyk, Júlia Hermes, Marica Grossegesse, Natalie Hofmann, Janine Michel, Markus Neumann, Andreas Nitsche, Berthold Hoppe, Tim Eckmanns, Hajo Schmidt-Traub, Kristina ZappelList of authors in order
- Landing page
-
https://doi.org/10.1186/s12879-024-09338-5Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1186/s12879-024-09338-5Direct OA link when available
- Concepts
-
Serology, Medicine, Vaccination, Pandemic, Coronavirus disease 2019 (COVID-19), Immunology, Cohort study, Virology, Antibody, Internal medicine, Disease, Infectious disease (medical specialty)Top concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 3Per-year citation counts (last 5 years)
- References (count)
-
37Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4395078149 |
|---|---|
| doi | https://doi.org/10.1186/s12879-024-09338-5 |
| ids.doi | https://doi.org/10.1186/s12879-024-09338-5 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38658874 |
| ids.openalex | https://openalex.org/W4395078149 |
| fwci | 6.22867199 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000706 |
| mesh[1].descriptor_ui | D006282 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | statistics & numerical data |
| mesh[1].descriptor_name | Health Personnel |
| mesh[2].qualifier_ui | Q000517 |
| mesh[2].descriptor_ui | D000086382 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | prevention & control |
| mesh[2].descriptor_name | COVID-19 |
| mesh[3].qualifier_ui | Q000276 |
| mesh[3].descriptor_ui | D000086382 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | immunology |
| mesh[3].descriptor_name | COVID-19 |
| mesh[4].qualifier_ui | Q000453 |
| mesh[4].descriptor_ui | D000086382 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | epidemiology |
| mesh[4].descriptor_name | COVID-19 |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D008297 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Male |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D005260 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Female |
| mesh[7].qualifier_ui | Q000097 |
| mesh[7].descriptor_ui | D000914 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | blood |
| mesh[7].descriptor_name | Antibodies, Viral |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000328 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Adult |
| mesh[9].qualifier_ui | Q000276 |
| mesh[9].descriptor_ui | D000086402 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | immunology |
| mesh[9].descriptor_name | SARS-CoV-2 |
| mesh[10].qualifier_ui | Q000276 |
| mesh[10].descriptor_ui | D000086663 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | immunology |
| mesh[10].descriptor_name | COVID-19 Vaccines |
| mesh[11].qualifier_ui | Q000008 |
| mesh[11].descriptor_ui | D000086663 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | administration & dosage |
| mesh[11].descriptor_name | COVID-19 Vaccines |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D008875 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Middle Aged |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D007117 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Immunization, Secondary |
| mesh[14].qualifier_ui | Q000453 |
| mesh[14].descriptor_ui | D005858 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | epidemiology |
| mesh[14].descriptor_name | Germany |
| mesh[15].qualifier_ui | Q000097 |
| mesh[15].descriptor_ui | D007074 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | blood |
| mesh[15].descriptor_name | Immunoglobulin G |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D005500 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Follow-Up Studies |
| mesh[17].qualifier_ui | Q000276 |
| mesh[17].descriptor_ui | D000090982 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | immunology |
| mesh[17].descriptor_name | BNT162 Vaccine |
| mesh[18].qualifier_ui | Q000008 |
| mesh[18].descriptor_ui | D000090982 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | administration & dosage |
| mesh[18].descriptor_name | BNT162 Vaccine |
| mesh[19].qualifier_ui | Q000276 |
| mesh[19].descriptor_ui | D000090985 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | immunology |
| mesh[19].descriptor_name | ChAdOx1 nCoV-19 |
| mesh[20].qualifier_ui | Q000008 |
| mesh[20].descriptor_ui | D000090985 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | administration & dosage |
| mesh[20].descriptor_name | ChAdOx1 nCoV-19 |
| mesh[21].qualifier_ui | Q000706 |
| mesh[21].descriptor_ui | D014611 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | statistics & numerical data |
| mesh[21].descriptor_name | Vaccination |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D015331 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Cohort Studies |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D006801 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Humans |
| mesh[24].qualifier_ui | Q000706 |
| mesh[24].descriptor_ui | D006282 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | statistics & numerical data |
| mesh[24].descriptor_name | Health Personnel |
| mesh[25].qualifier_ui | Q000517 |
| mesh[25].descriptor_ui | D000086382 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | prevention & control |
| mesh[25].descriptor_name | COVID-19 |
| mesh[26].qualifier_ui | Q000276 |
| mesh[26].descriptor_ui | D000086382 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | immunology |
| mesh[26].descriptor_name | COVID-19 |
| mesh[27].qualifier_ui | Q000453 |
| mesh[27].descriptor_ui | D000086382 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | epidemiology |
| mesh[27].descriptor_name | COVID-19 |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D008297 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Male |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D005260 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Female |
| mesh[30].qualifier_ui | Q000097 |
| mesh[30].descriptor_ui | D000914 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | blood |
| mesh[30].descriptor_name | Antibodies, Viral |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000328 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Adult |
| mesh[32].qualifier_ui | Q000276 |
| mesh[32].descriptor_ui | D000086402 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | immunology |
| mesh[32].descriptor_name | SARS-CoV-2 |
| mesh[33].qualifier_ui | Q000276 |
| mesh[33].descriptor_ui | D000086663 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | immunology |
| mesh[33].descriptor_name | COVID-19 Vaccines |
| mesh[34].qualifier_ui | Q000008 |
| mesh[34].descriptor_ui | D000086663 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | administration & dosage |
| mesh[34].descriptor_name | COVID-19 Vaccines |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D008875 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Middle Aged |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D007117 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Immunization, Secondary |
| mesh[37].qualifier_ui | Q000453 |
| mesh[37].descriptor_ui | D005858 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | epidemiology |
| mesh[37].descriptor_name | Germany |
| mesh[38].qualifier_ui | Q000097 |
| mesh[38].descriptor_ui | D007074 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | blood |
| mesh[38].descriptor_name | Immunoglobulin G |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D005500 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Follow-Up Studies |
| mesh[40].qualifier_ui | Q000276 |
| mesh[40].descriptor_ui | D000090982 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | immunology |
| mesh[40].descriptor_name | BNT162 Vaccine |
| mesh[41].qualifier_ui | Q000008 |
| mesh[41].descriptor_ui | D000090982 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | administration & dosage |
| mesh[41].descriptor_name | BNT162 Vaccine |
| mesh[42].qualifier_ui | Q000276 |
| mesh[42].descriptor_ui | D000090985 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | immunology |
| mesh[42].descriptor_name | ChAdOx1 nCoV-19 |
| mesh[43].qualifier_ui | Q000008 |
| mesh[43].descriptor_ui | D000090985 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | administration & dosage |
| mesh[43].descriptor_name | ChAdOx1 nCoV-19 |
| mesh[44].qualifier_ui | Q000706 |
| mesh[44].descriptor_ui | D014611 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | statistics & numerical data |
| mesh[44].descriptor_name | Vaccination |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D015331 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Cohort Studies |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D006801 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Humans |
| mesh[47].qualifier_ui | Q000706 |
| mesh[47].descriptor_ui | D006282 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | statistics & numerical data |
| mesh[47].descriptor_name | Health Personnel |
| mesh[48].qualifier_ui | Q000517 |
| mesh[48].descriptor_ui | D000086382 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | prevention & control |
| mesh[48].descriptor_name | COVID-19 |
| mesh[49].qualifier_ui | Q000276 |
| mesh[49].descriptor_ui | D000086382 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | immunology |
| mesh[49].descriptor_name | COVID-19 |
| type | article |
| title | Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination |
| biblio.issue | 1 |
| biblio.volume | 24 |
| biblio.last_page | 436 |
| biblio.first_page | 436 |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T10041 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9962999820709229 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | COVID-19 Clinical Research Studies |
| topics[2].id | https://openalex.org/T11495 |
| topics[2].field.id | https://openalex.org/fields/11 |
| topics[2].field.display_name | Agricultural and Biological Sciences |
| topics[2].score | 0.9876000285148621 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1103 |
| topics[2].subfield.display_name | Animal Science and Zoology |
| topics[2].display_name | Animal Virus Infections Studies |
| is_xpac | False |
| apc_list.value | 1690 |
| apc_list.currency | GBP |
| apc_list.value_usd | 2072 |
| apc_paid.value | 1690 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 2072 |
| concepts[0].id | https://openalex.org/C45189115 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8481391668319702 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q502159 |
| concepts[0].display_name | Serology |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8399257659912109 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C22070199 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7276405096054077 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q192995 |
| concepts[2].display_name | Vaccination |
| concepts[3].id | https://openalex.org/C89623803 |
| concepts[3].level | 5 |
| concepts[3].score | 0.5460179448127747 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12184 |
| concepts[3].display_name | Pandemic |
| concepts[4].id | https://openalex.org/C3008058167 |
| concepts[4].level | 4 |
| concepts[4].score | 0.4818607270717621 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[4].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[5].id | https://openalex.org/C203014093 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4589347541332245 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[5].display_name | Immunology |
| concepts[6].id | https://openalex.org/C201903717 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4192259907722473 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1778788 |
| concepts[6].display_name | Cohort study |
| concepts[7].id | https://openalex.org/C159047783 |
| concepts[7].level | 1 |
| concepts[7].score | 0.38097822666168213 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[7].display_name | Virology |
| concepts[8].id | https://openalex.org/C159654299 |
| concepts[8].level | 2 |
| concepts[8].score | 0.37293732166290283 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[8].display_name | Antibody |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.36679238080978394 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C2779134260 |
| concepts[10].level | 2 |
| concepts[10].score | 0.16507813334465027 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[10].display_name | Disease |
| concepts[11].id | https://openalex.org/C524204448 |
| concepts[11].level | 3 |
| concepts[11].score | 0.1502542793750763 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[11].display_name | Infectious disease (medical specialty) |
| keywords[0].id | https://openalex.org/keywords/serology |
| keywords[0].score | 0.8481391668319702 |
| keywords[0].display_name | Serology |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.8399257659912109 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/vaccination |
| keywords[2].score | 0.7276405096054077 |
| keywords[2].display_name | Vaccination |
| keywords[3].id | https://openalex.org/keywords/pandemic |
| keywords[3].score | 0.5460179448127747 |
| keywords[3].display_name | Pandemic |
| keywords[4].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[4].score | 0.4818607270717621 |
| keywords[4].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[5].id | https://openalex.org/keywords/immunology |
| keywords[5].score | 0.4589347541332245 |
| keywords[5].display_name | Immunology |
| keywords[6].id | https://openalex.org/keywords/cohort-study |
| keywords[6].score | 0.4192259907722473 |
| keywords[6].display_name | Cohort study |
| keywords[7].id | https://openalex.org/keywords/virology |
| keywords[7].score | 0.38097822666168213 |
| keywords[7].display_name | Virology |
| keywords[8].id | https://openalex.org/keywords/antibody |
| keywords[8].score | 0.37293732166290283 |
| keywords[8].display_name | Antibody |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.36679238080978394 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/disease |
| keywords[10].score | 0.16507813334465027 |
| keywords[10].display_name | Disease |
| keywords[11].id | https://openalex.org/keywords/infectious-disease |
| keywords[11].score | 0.1502542793750763 |
| keywords[11].display_name | Infectious disease (medical specialty) |
| language | en |
| locations[0].id | doi:10.1186/s12879-024-09338-5 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S171015910 |
| locations[0].source.issn | 1471-2334 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1471-2334 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | BMC Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310320256 |
| locations[0].source.host_organization_name | BioMed Central |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320256, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | BioMed Central, Springer Nature |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | BMC Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1186/s12879-024-09338-5 |
| locations[1].id | pmid:38658874 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | BMC infectious diseases |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38658874 |
| locations[2].id | pmh:oai:doaj.org/article:87716b3765c24e8889771bf5557b2062 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-12 (2024) |
| locations[2].landing_page_url | https://doaj.org/article/87716b3765c24e8889771bf5557b2062 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11040945 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | BMC Infect Dis |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11040945 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5108728056 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Alexander Hönning |
| authorships[0].countries | DE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210108951 |
| authorships[0].affiliations[0].raw_affiliation_string | Centre for Clinical Research, BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany. [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I4210108951 |
| authorships[0].institutions[0].ror | https://ror.org/011zjcv36 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210108951 |
| authorships[0].institutions[0].country_code | DE |
| authorships[0].institutions[0].display_name | Unfallkrankenhaus Berlin |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Alexander Hönning |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Centre for Clinical Research, BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany. [email protected]. |
| authorships[1].author.id | https://openalex.org/A5005558751 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6975-2663 |
| authorships[1].author.display_name | Sara Tomczyk |
| authorships[1].countries | DE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I24359323 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. |
| authorships[1].institutions[0].id | https://openalex.org/I24359323 |
| authorships[1].institutions[0].ror | https://ror.org/01k5qnb77 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I24359323 |
| authorships[1].institutions[0].country_code | DE |
| authorships[1].institutions[0].display_name | Robert Koch Institute |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Sara Tomczyk |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. |
| authorships[2].author.id | https://openalex.org/A5111430838 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Júlia Hermes |
| authorships[2].countries | DE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I24359323 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. |
| authorships[2].institutions[0].id | https://openalex.org/I24359323 |
| authorships[2].institutions[0].ror | https://ror.org/01k5qnb77 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I24359323 |
| authorships[2].institutions[0].country_code | DE |
| authorships[2].institutions[0].display_name | Robert Koch Institute |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Julia Hermes |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. |
| authorships[3].author.id | https://openalex.org/A5004843696 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9369-8203 |
| authorships[3].author.display_name | Marica Grossegesse |
| authorships[3].countries | DE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I24359323 |
| authorships[3].affiliations[0].raw_affiliation_string | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[3].institutions[0].id | https://openalex.org/I24359323 |
| authorships[3].institutions[0].ror | https://ror.org/01k5qnb77 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I24359323 |
| authorships[3].institutions[0].country_code | DE |
| authorships[3].institutions[0].display_name | Robert Koch Institute |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Marica Grossegesse |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[4].author.id | https://openalex.org/A5060276906 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-6282-5364 |
| authorships[4].author.display_name | Natalie Hofmann |
| authorships[4].countries | DE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I24359323 |
| authorships[4].affiliations[0].raw_affiliation_string | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[4].institutions[0].id | https://openalex.org/I24359323 |
| authorships[4].institutions[0].ror | https://ror.org/01k5qnb77 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I24359323 |
| authorships[4].institutions[0].country_code | DE |
| authorships[4].institutions[0].display_name | Robert Koch Institute |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Natalie Hofmann |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[5].author.id | https://openalex.org/A5066932819 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-6227-3125 |
| authorships[5].author.display_name | Janine Michel |
| authorships[5].countries | DE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I24359323 |
| authorships[5].affiliations[0].raw_affiliation_string | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[5].institutions[0].id | https://openalex.org/I24359323 |
| authorships[5].institutions[0].ror | https://ror.org/01k5qnb77 |
| authorships[5].institutions[0].type | government |
| authorships[5].institutions[0].lineage | https://openalex.org/I24359323 |
| authorships[5].institutions[0].country_code | DE |
| authorships[5].institutions[0].display_name | Robert Koch Institute |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Janine Michel |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[6].author.id | https://openalex.org/A5051879208 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9430-5766 |
| authorships[6].author.display_name | Markus Neumann |
| authorships[6].countries | DE |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I24359323 |
| authorships[6].affiliations[0].raw_affiliation_string | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[6].institutions[0].id | https://openalex.org/I24359323 |
| authorships[6].institutions[0].ror | https://ror.org/01k5qnb77 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I24359323 |
| authorships[6].institutions[0].country_code | DE |
| authorships[6].institutions[0].display_name | Robert Koch Institute |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Markus Neumann |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[7].author.id | https://openalex.org/A5007303691 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8185-3176 |
| authorships[7].author.display_name | Andreas Nitsche |
| authorships[7].countries | DE |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I24359323 |
| authorships[7].affiliations[0].raw_affiliation_string | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[7].institutions[0].id | https://openalex.org/I24359323 |
| authorships[7].institutions[0].ror | https://ror.org/01k5qnb77 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I24359323 |
| authorships[7].institutions[0].country_code | DE |
| authorships[7].institutions[0].display_name | Robert Koch Institute |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Andreas Nitsche |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany. |
| authorships[8].author.id | https://openalex.org/A5101871418 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-0784-4017 |
| authorships[8].author.display_name | Berthold Hoppe |
| authorships[8].countries | DE |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I176453806 |
| authorships[8].affiliations[0].raw_affiliation_string | Health and Medical University Potsdam, Potsdam, Germany. |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I4210108951 |
| authorships[8].affiliations[1].raw_affiliation_string | Institute of Laboratory Medicine, BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany. |
| authorships[8].institutions[0].id | https://openalex.org/I4210108951 |
| authorships[8].institutions[0].ror | https://ror.org/011zjcv36 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210108951 |
| authorships[8].institutions[0].country_code | DE |
| authorships[8].institutions[0].display_name | Unfallkrankenhaus Berlin |
| authorships[8].institutions[1].id | https://openalex.org/I176453806 |
| authorships[8].institutions[1].ror | https://ror.org/03bnmw459 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I176453806 |
| authorships[8].institutions[1].country_code | DE |
| authorships[8].institutions[1].display_name | University of Potsdam |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Berthold Hoppe |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Health and Medical University Potsdam, Potsdam, Germany., Institute of Laboratory Medicine, BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany. |
| authorships[9].author.id | https://openalex.org/A5041313004 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-4022-4944 |
| authorships[9].author.display_name | Tim Eckmanns |
| authorships[9].countries | DE |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I24359323 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. |
| authorships[9].institutions[0].id | https://openalex.org/I24359323 |
| authorships[9].institutions[0].ror | https://ror.org/01k5qnb77 |
| authorships[9].institutions[0].type | government |
| authorships[9].institutions[0].lineage | https://openalex.org/I24359323 |
| authorships[9].institutions[0].country_code | DE |
| authorships[9].institutions[0].display_name | Robert Koch Institute |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Tim Eckmanns |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. |
| authorships[10].author.id | https://openalex.org/A5063180162 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Hajo Schmidt-Traub |
| authorships[10].countries | DE |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210108951 |
| authorships[10].affiliations[0].raw_affiliation_string | BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany. |
| authorships[10].institutions[0].id | https://openalex.org/I4210108951 |
| authorships[10].institutions[0].ror | https://ror.org/011zjcv36 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210108951 |
| authorships[10].institutions[0].country_code | DE |
| authorships[10].institutions[0].display_name | Unfallkrankenhaus Berlin |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Hajo Schmidt-Traub |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany. |
| authorships[11].author.id | https://openalex.org/A5063862614 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Kristina Zappel |
| authorships[11].countries | DE |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210108951 |
| authorships[11].affiliations[0].raw_affiliation_string | Centre for Clinical Research, BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany. |
| authorships[11].institutions[0].id | https://openalex.org/I4210108951 |
| authorships[11].institutions[0].ror | https://ror.org/011zjcv36 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210108951 |
| authorships[11].institutions[0].country_code | DE |
| authorships[11].institutions[0].display_name | Unfallkrankenhaus Berlin |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Kristina Zappel |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Centre for Clinical Research, BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1186/s12879-024-09338-5 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W2050449690, https://openalex.org/W2019814523, https://openalex.org/W3136336094, https://openalex.org/W2181379447, https://openalex.org/W197331344, https://openalex.org/W1979560439, https://openalex.org/W1966774525, https://openalex.org/W2766329113, https://openalex.org/W2105748230, https://openalex.org/W2089074812 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1186/s12879-024-09338-5 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S171015910 |
| best_oa_location.source.issn | 1471-2334 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1471-2334 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | BMC Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310320256 |
| best_oa_location.source.host_organization_name | BioMed Central |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320256, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | BioMed Central, Springer Nature |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | BMC Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s12879-024-09338-5 |
| primary_location.id | doi:10.1186/s12879-024-09338-5 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S171015910 |
| primary_location.source.issn | 1471-2334 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1471-2334 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | BMC Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310320256 |
| primary_location.source.host_organization_name | BioMed Central |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320256, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | BioMed Central, Springer Nature |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | BMC Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1186/s12879-024-09338-5 |
| publication_date | 2024-04-24 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4207020509, https://openalex.org/W4220777055, https://openalex.org/W4383550993, https://openalex.org/W4226246149, https://openalex.org/W4281264059, https://openalex.org/W4378515088, https://openalex.org/W4283361551, https://openalex.org/W3215520010, https://openalex.org/W3203611764, https://openalex.org/W4282965950, https://openalex.org/W4280583884, https://openalex.org/W4317356311, https://openalex.org/W3023891023, https://openalex.org/W4206932047, https://openalex.org/W4206494188, https://openalex.org/W4315640731, https://openalex.org/W3200762609, https://openalex.org/W3133659396, https://openalex.org/W3169799087, https://openalex.org/W3170306142, https://openalex.org/W3146894320, https://openalex.org/W3144728481, https://openalex.org/W3032642702, https://openalex.org/W3183277931, https://openalex.org/W3091912491, https://openalex.org/W4220961659, https://openalex.org/W4283709513, https://openalex.org/W3194347237, https://openalex.org/W3146538993, https://openalex.org/W3159795186, https://openalex.org/W3167263725, https://openalex.org/W3153468502, https://openalex.org/W3176479223, https://openalex.org/W3176796768, https://openalex.org/W4226470088, https://openalex.org/W4224950216, https://openalex.org/W4225854071 |
| referenced_works_count | 37 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 96 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 12 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.91388661 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |